UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000036375 |
|---|---|
| Receipt number | R000041398 |
| Scientific Title | Efficacy and safety of VRd (bortezomib, lenalidomide, dexamethasone) induction therapy, autologous hematopoietic stem cell transplantation, KRd (carfilzomib, lenalidomide, dexamethasone) consolidation and lenalidomide maintenance therapy for newly diagnosed multiple myeloma (phase II study) |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2023/10/04 15:05:25 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/04/01 18:46:05 | ||
| 2 | Update | 2019/07/03 10:08:53 | UMIN ID1 |
|
| 3 | Update | 2019/07/03 10:11:55 | Recruitment status Date of IRB |
|
| 4 | Update | 2019/12/27 10:12:52 | Email1 |
|
| 5 | Update | 2020/01/20 19:28:49 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
| 6 | Update | 2021/06/29 14:03:35 | Email1 |
|
| 7 | Update | 2021/07/14 15:29:12 | Email1 |
|
| 8 | Update | 2023/04/30 11:31:37 | Last follow-up date |
|
| 9 | Update | 2023/04/30 11:32:29 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator |
|
| 10 | Update | 2023/10/04 15:05:26 | Last follow-up date |
